Publication | Open Access
<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer
95
Citations
38
References
2024
Year
<i>NECTIN4</i> amplifications are genomic predictors of EV responses and long-term survival in patients with mUC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1